IDH2 and acute myeloid leukemia: Studies have confirmed that the active IDH2-mediated reductive TCA cycle in acute myeloid leukemia (AML) cells promotes the conversion of α-KG to isocitrate/citrate, thereby facilitating the synthesis of lipids from glutamine [13].